drugset / Trial / NCT01390064
Vaccination of High Risk Breast Cancer Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Objective - Determine the safety and tolerability of a peptide mimotope-based vaccine upon immunization of breast cancer subjects.
Timeline
- Start
- 2011-07
- Primary completion
- 2018-07
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mimotope P10s-PADRE | Vaccine | 100 ug | Subcutaneous |
| Subject | Mimotope P10s-PADRE | Vaccine | 300 ug | Subcutaneous |
| Subject | Mimotope P10s-PADRE | Vaccine | 500 ug | Subcutaneous |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | Subcutaneous |